• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    52 Biggest Movers From Friday

    1/18/22 5:26:50 AM ET
    $ADCT
    $ADGI
    $APT
    $ATIP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADCT alert in real time by email

    Gainers

    • Splash Beverage Group, Inc. (NASDAQ:SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) rose 54.3% to close at $1.62 after the company announced the planned expansion of its Robotics as a Service offering with the proposed acquisition of Shenzhen Keweien Robot Service Co. and Guangzhou Kewei Robot Technology Co.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) shares jumped 27% to close at $20.87.
    • ATI Physical Therapy, Inc. (NYSE:ATIP) shares surged 23.4% to close at $3.75 on Friday after Jefferies upgraded the stock from Hold to Buy and raised its price target from $3.50 to $5.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) rose 23.2% to settle at $11.73. Theseus Pharmaceuticals recently said first patient was treated with THE-630 in Phase 1/2 study in patients with advanced gastrointestinal stromal tumors.
    • ShiftPixy, Inc. (NASDAQ:PIXY) gained 22.9% to close at $1.29.
    • Integrated Media Technology Limited (NASDAQ:IMTE) surged 19.8% to close at $8.77. Integrated Media Technology recently entered into convertible note purchase agreements with eight individual investors to raise $10 million.
    • Prometheus Biosciences, Inc. (NASDAQ:RXDX)gained 17.1% to settle at $35.29.
    • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) shares jumped 16.6% to close at $11.10. Shares of Macau casino stocks traded higher following the release of a new Macau gaming bill that was mostly in-line with expectations but that had at least a couple of bullish surprises for investors.
    • Cardiol Therapeutics Inc. (NASDAQ:CRDL) gained 16.3% to close at $2.00.
    • Ucommune International Ltd (NASDAQ:UK) jumped 15.4% to settle at $0.90. Ucommune International recently signed an agreement with Nanchang Qinghu Industrial Park Management Company to jointly develop the Nanchang Honggutan-Ucommune project.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) rose 15.3% to close at $4.07 after gaining around 23% on Thursday.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 15.2% to close at $0.7804 following Q3 results. NextPlay Technologies reported quarterly gross profit of $2.2 million and sales of $4.2 million.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) jumped 14.6% to settle at $0.4240.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) gained 14.3% to close at $0.72.
    • Las Vegas Sands Corp. (NYSE:LVS) rose 14.2% to close at $42.99. Shares of Macau casino stocks traded higher following the release of a new Macau gaming bill that was mostly in-line with expectations but that had at least a couple of bullish surprises for investors.
    • SmileDirectClub, Inc. (NASDAQ:SDC) gained 14.2% to settle at $2.25.
    • Fathom Digital Manufacturing Corporation (NYSE:FATH) gained 13.9% to close at $7.89.
    • Planet Labs PBC (NYSE:PL) gained 13.8% to close at $6.36.
    • Indonesia Energy Corporation Limited (NYSE:INDO) rose 13.2% to close at $3.28.
    • Reliance Global Group, Inc. (NASDAQ:RELI) jumped 13% to settle at $8.96.
    • Molecular Partners AG (NASDAQ:MOLN) shares gained 12.7% to close at $31.89. Molecular Partners said Essex Woodlands Health Ventures Funds crossed below the 3% threshold, transacting its remaining shares to BVF Partners L.P., whose holdings have now crossed the 10% threshold, rising to 12.21%. The company has licensed its COVID-19 treatment candidate to Novartis.
    • Zovio Inc (NASDAQ:ZVO) gained 12.3% to settle at $1.37. Zovio's Fullstack Academy recently reported a partnership with upGrad to introduce cybersecurity, data analytics bootcamps in India.
    • Wynn Resorts, Limited (NASDAQ:WYNN) rose 8.6% to close at $91.47. Shares of Macau casino stocks traded higher following the release of a new Macau gaming bill that was mostly in-line with expectations but that had at least a couple of bullish surprises for investors.
    • Adagio Therapeutics, Inc. (NASDAQ:ADGI) gained 8.4% to close at $5.70. Adagio Therapeutics recently summarized recent findings reported in three separate publications that show ADG20 has neutralization activity against Omicron.

     

    Check out these big penny stock gainers and losers

    Losers

    • Cerberus Cyber Sentinel Corp (NASDAQ:CISO) shares dropped 25% to close at $5.42 on Friday. Cerberus Cyber Sentinel priced its initial public offering of 2,000,000 shares stock at a price of $5.00 per share.
    • Weidai Ltd. (NYSE:WEI) shares declined 20.5% to settle at $0.5801. Weidai said it will change the ratio of its American depositary shares.
    • Smith-Midland Corporation (NASDAQ:SMID) dropped 16.8% to close at $27.38.
    • FTC Solar, Inc. (NASDAQ:FTCI) shares fell 15.6% to close at $5.13 after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $9 to $5.
    • Dingdong (Cayman) Limited (NYSE:DDL) dipped 14.8% to settle at $8.63. The company’s board, last month, authorized a share repurchase program of up to $30.0 million of its shares.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) dropped 13.7% to close at $0.3850.
    • Insignia Systems, Inc. (NASDAQ:ISIG) fell 13.6% to close at $19.40.
    • Vaccitech plc (NASDAQ:VACC) dipped 13.3% to settle at $9.95.
    • GWG Holdings, Inc. (NASDAQ:GWGH) dropped 13.1% to close at $7.82.
    • Kelso Technologies Inc. (NYSE:KIQ) dipped 12.7% to close at $0.4801.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) fell 12.5% to settle at $0.6871. Journey Medical recently acquired Molecule Stabilizing Technology (MST) franchise, including Amzeeq (minocycline) topical foam and Zilxi (minocycline) topical foam from VYNE Therapeutics.
    • Codex DNA, Inc. (NASDAQ:DNAY) dipped 12.5% to close at $7.54. Codex DNA recently signed early access collaboration and licensing agreement with Pfizer to further develop Codex DNA's Novel Enzymatic DNA synthesis technology for Pfizer's use in its research and development of mRNA-based vaccines and biotherapies.
    • Nxt-ID, Inc. (NASDAQ:NXTD) fell 12.1% to close at $3.28.
    • Brilliant Earth Group, Inc. (NASDAQ:BRLT) declined 10.8% to close at $12.42.
    • Alpha Pro Tech, Ltd. (NYSE:APT) dropped 10.4% to close at $5.44.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) fell 10.3% to close at $6.90. Revelation Biosciences reported data demonstrating REVTx-99 in vitro anti-viral activity against SARS-CoV-2.
    • iSpecimen Inc. (NASDAQ:ISPC) dipped 10.1% to close at $6.25. iSpecimen, on Thursday, announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) fell 9.4% to close at $14.13. SOPHiA GENETICS recently reported strong traction in the launch phase of their DEEP-Lung-IV clinical study.
    • CureVac N.V. (NASDAQ:CVAC) fell 9.4% to close at $24.48.
    • ADC Therapeutics SA (NYSE:ADCT) fell 9.3% to close at $17.22.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) fell 9.1% to close at $8.55.
    • Orchid Island Capital, Inc. (NYSE:ORC) shares fell 7.9% to close at $4.22. Orchid Island Capital sees Q4 book value of $4.34 per share.
    • Perella Weinberg Partners (NASDAQ:PWP) fell 7.5% to close at $11.86 after the company announced a public offering of 3,500,000 shares of common stock.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) shares fell 7.4% to close at $4.64 after jumping over 25% on Thursday.
    • Imago BioSciences, Inc. (NASDAQ:IMGO) fell 7.4% to close at $18.48.
    • JPMorgan Chase & Co. (NYSE:JPM) dropped 6.2% to close at $157.89 after reporting Q4 results.
    • PagSeguro Digital Ltd. (NYSE:PAGS) fell 4.7% to settle at $22.45. Keybanc downgraded PagSeguro Digital from Overweight to Sector Weight.
    Get the next $ADCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADCT
    $ADGI
    $APT
    $ATIP

    CompanyDatePrice TargetRatingAnalyst
    JP Morgan Chase & Co.
    $JPM
    2/3/2026$280.00Underperform → Neutral
    Robert W. Baird
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Melco Resorts & Entertainment Limited
    $MLCO
    1/16/2026$7.70Overweight → Neutral
    Analyst
    JP Morgan Chase & Co.
    $JPM
    1/7/2026Outperform → Peer Perform
    Wolfe Research
    Las Vegas Sands Corp.
    $LVS
    12/15/2025$80.00Neutral → Buy
    Goldman
    Orchid Island Capital Inc.
    $ORC
    12/15/2025$7.50Neutral
    Compass Point
    Planet Labs PBC
    $PL
    12/12/2025$19.00Buy
    Citigroup
    Wynn Resorts Limited
    $WYNN
    11/21/2025$160.00Neutral → Buy
    Citigroup
    More analyst ratings

    $ADCT
    $ADGI
    $APT
    $ATIP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: Large owner Donahue Kevin Michael bought $1,034,350 worth of shares (685,000 units at $1.51) (SEC Form 4)

    4/A - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/20/26 10:29:36 AM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Donahue Kevin Michael bought $258,827,700,000 worth of shares (643,850 units at $402,000.00) (SEC Form 4)

    4 - MAINZ BIOMED N.V. (0001874252) (Issuer)

    1/16/26 3:42:37 PM ET
    $MYNZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (ORIG-1) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 04/23/2021. Application Category: BLA, Application Number: 761196, Application Classification:

    4/23/21 1:46:03 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    JPMorgan Chase upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded JPMorgan Chase from Underperform to Neutral and set a new price target of $280.00

    2/3/26 6:50:14 AM ET
    $JPM
    Major Banks
    Finance

    H.C. Wainwright initiated coverage on Molecular Partners AG with a new price target

    H.C. Wainwright initiated coverage of Molecular Partners AG with a rating of Buy and set a new price target of $13.00

    1/27/26 8:47:34 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Melco Resorts & Entertainment downgraded by Analyst with a new price target

    Analyst downgraded Melco Resorts & Entertainment from Overweight to Neutral and set a new price target of $7.70

    1/16/26 8:31:45 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    $ADCT
    $ADGI
    $APT
    $ATIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Goldstein Robert G converted options into 65,167 shares, increasing direct ownership by 50% to 195,855 units (SEC Form 4)

    4 - LAS VEGAS SANDS CORP (0001300514) (Issuer)

    2/5/26 8:05:27 PM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    President & COO Dumont Patrick covered exercise/tax liability with 13,151 shares and converted options into 33,419 shares, increasing direct ownership by 4% to 510,367 units (SEC Form 4)

    4 - LAS VEGAS SANDS CORP (0001300514) (Issuer)

    2/5/26 8:04:22 PM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    EVP and Global General Counsel Hudson D. Zachary converted options into 17,378 shares, increasing direct ownership by 63% to 45,023 units (SEC Form 4)

    4 - LAS VEGAS SANDS CORP (0001300514) (Issuer)

    2/5/26 8:03:07 PM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    $ADCT
    $ADGI
    $APT
    $ATIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete

    Live Production Marketplace Now AvailableWoburn, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC) today announced the successful completion of Milestone 2, System Integration and Marketplace Activation, marking a pivotal step in the SalesStack digital transformation journey. The milestone delivers a fully integrated, live marketplace that connects customer requests with supplier inventories, enabling streamlined operations, reduced costs, and a foundation for future growth.Chief Executive Officer Ms. Katie Field commented, "This Milestone 2 achievement demonstrates end-to-end system integration, legacy data migration, and activation of a production-ready Sale

    2/6/26 9:30:00 AM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Bimini Capital Management to Announce Fourth Quarter 2025 Results

    VERO BEACH, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB:BMNM) ("Bimini" or the "Company"), today announced that it will release results for the fourth quarter of 2025 following the close of trading on Thursday, March 5, 2026. Earnings Conference Call Details An earnings conference call and live audio webcast will be hosted Friday, March 6, 2026, at 10:00 AM ET. Participants can register and receive dial-in information at https://register-conf.media-server.com/register/BI5b52747f39b248e6bdb12a6e39cbfd09. A live audio webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/u2f5cgxh or via the investor relations section of the

    2/6/26 8:36:12 AM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    iSpecimen Achieves Rapid Procurement Milestone for Influenza Research

    Lexington, Massachusetts--(Newsfile Corp. - February 6, 2026) - iSpecimen Inc. (NASDAQ:ISPC), a leading provider of human biospecimens for research, is proud to announce recent milestones that demonstrate the strength, responsiveness, and reliability of its site network.Over the past several months, iSpecimen has been actively supporting customer research by sourcing high-quality respiratory samples, with a particular focus on influenza. Most recently, iSpecimen successfully collected 500 influenza swab samples in just a few weeks to support a customer research project—demonstrating its ability to respond quickly to time-sensitive research needs. The rapid turnaround and quality of the speci

    2/6/26 8:20:00 AM ET
    $ISPC
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ADCT
    $ADGI
    $APT
    $ATIP
    SEC Filings

    View All

    SEC Form 10-K filed by Las Vegas Sands Corp.

    10-K - LAS VEGAS SANDS CORP (0001300514) (Filer)

    2/6/26 4:45:07 PM ET
    $LVS
    Hotels/Resorts
    Consumer Discretionary

    SEC Form PRE 14A filed by Revelation Biosciences Inc.

    PRE 14A - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

    2/6/26 4:32:19 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by Perella Weinberg Partners

    S-8 - Perella Weinberg Partners (0001777835) (Filer)

    2/6/26 4:28:29 PM ET
    $PWP
    Finance: Consumer Services
    Finance

    $ADCT
    $ADGI
    $APT
    $ATIP
    Leadership Updates

    Live Leadership Updates

    View All

    J.P. Morgan Asset Management Welcomes Pam Hess as Retirement Strategist

    Experienced retirement research expert to help meet increased demand for actionable retirement insights NEW YORK, Jan. 27, 2026 /PRNewswire/ -- J.P. Morgan Asset Management today announced the appointment of Pam Hess as Executive Director and Retirement Strategist on the Retirement Insights team reporting to Michael Conrath, Chief Retirement Strategist. This key hire reflects the firm's ongoing commitment to investing in resources that help financial professionals, participants and plan sponsors navigate today's complex retirement landscape. In this role, Pam supports the deve

    1/27/26 10:00:00 AM ET
    $JPM
    Major Banks
    Finance

    CISO Global Partners with TeleDental to Launch CyberSimple® Powered by CHECKLIGHT® to Protect Dental Clinics From Cyber Threats

    Scottsdale, AZ, Jan. 15, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced a strategic partnership with TeleDental.com and DentalChat.com to offer Cyber Assurance Group's CyberSimple® powered by CHECKLIGHT®, delivering cybersecurity and financial protection purpose-built for dental practices. Through this collaboration, CyberSimple® powered by CHECKLIGHT® will be made available via TeleDental.com and DentalChat.com, initially extending protection to more than 358 dental clinics nationwide, with significant expansion potential across the broader U.S. dental market. This effort underline

    1/15/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    FTC Solar Appoints Wes Fuller VP, North America Utility Sales

    AUSTIN, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (NASDAQ:FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has named Wes Fuller as its Vice President of North America Utility Sales. Fuller will report to Kent James, Chief Commercial Officer for North America. "Wes has an extensive track record of commercial leadership across the renewables industry, including trackers and energy storage," said Kent James. "His expertise, leadership and deep industry relationships will be instrumental in expanding our reach and delivering innovative tracker solutions to our customers." "I am thrilled to join FTC Solar at such a

    1/13/26 8:02:00 AM ET
    $FTCI
    Semiconductors
    Technology

    $ADCT
    $ADGI
    $APT
    $ATIP
    Financials

    Live finance-specific insights

    View All

    Bimini Capital Management to Announce Fourth Quarter 2025 Results

    VERO BEACH, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB:BMNM) ("Bimini" or the "Company"), today announced that it will release results for the fourth quarter of 2025 following the close of trading on Thursday, March 5, 2026. Earnings Conference Call Details An earnings conference call and live audio webcast will be hosted Friday, March 6, 2026, at 10:00 AM ET. Participants can register and receive dial-in information at https://register-conf.media-server.com/register/BI5b52747f39b248e6bdb12a6e39cbfd09. A live audio webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/u2f5cgxh or via the investor relations section of the

    2/6/26 8:36:12 AM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    Perella Weinberg Reports Full Year and Fourth Quarter 2025 Results

    Financial Overview - Full Year Revenues of $751 Million, Down 14% From a Record 2024GAAP Pre-Tax Income of $52 Million, Adjusted Pre-Tax Income of $82 MillionGAAP Diluted EPS of $0.47, Adjusted EPS of $0.68 Financial Overview - Fourth Quarter Revenues of $219 Million, Down 3% From a Year Ago and Up 33% From Last QuarterGAAP Pre-Tax Income of $22 Million, Adjusted Pre-Tax Income of $29 MillionGAAP Diluted EPS of $0.10, Adjusted EPS of $0.17 Talent Investment Added Twelve Partners and Eleven Managing Directors in 2025Two Partners Added in 2026 Year-To-DateAcquired Devon Park Advisors, Establishing Secondaries Advisory Capability Capital Management Strong Balance Sheet with $256 Million

    2/6/26 6:59:00 AM ET
    $PWP
    Finance: Consumer Services
    Finance

    Melco Announces Earnings Release Date

    MACAU, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (NASDAQ:MLCO), a developer, owner and operator of integrated resort facilities in Asia and Europe, today announces that it will release its unaudited financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 12, 2026 to be followed by a conference call on the same day at 8:30 a.m. Eastern Time (or 9:30 p.m. Singapore Time). To join the conference call, please register in advance using the below Online Registration Link. Upon registering, each participant will receive the dial-in numbers, passcode and a unique Personal PIN which can be used to join the conference. Onli

    2/5/26 6:54:47 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    $ADCT
    $ADGI
    $APT
    $ATIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Smith-Midland Corporation

    SC 13D/A - SMITH MIDLAND CORP (0000924719) (Subject)

    12/10/24 3:10:37 PM ET
    $SMID
    Building Materials
    Industrials

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/2/24 4:57:34 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care